{"id":"W4318539727","doi":"10.1093/ecco-jcc/jjac190.0777","title":"P647 Outcomes following the use of vedolizumab first line versus second line in Ulcerative Colitis: a single centre experience","year":2023,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Vedolizumab; Medicine; Infliximab; Ulcerative colitis; Adalimumab; Golimumab; Internal medicine; Inflammatory bowel disease; Demographics; Gastroenterology; Surgery; Disease; Demography","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00120966,0.0001835674,0.0008843767,0.0004188797,0.0004166813,0.001271471,0.0003307466,0.0004177733,0.001177052],"category_scores_gemma":[0.004142414,0.0001769613,0.000724233,0.000750589,0.0003944788,0.0005597288,0.0007859939,0.0006269854,0.0002167264],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006506528,"about_ca_system_score_gemma":0.0005814438,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008144539,"about_ca_topic_score_gemma":0.0009629549,"domain_scores_codex":[0.9985475,0.0005605968,0.0001943224,0.0002624259,0.000234267,0.0002009006],"domain_scores_gemma":[0.9961414,0.000760358,0.001934996,0.0001322094,0.0002090417,0.0008220932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004302112,0.0006150727,0.9645975,0.0003298543,0.0004221409,0.00258891,0.000776421,0.0002057256,0.001047598,0.00008163666,0.0005342201,0.02449872],"study_design_scores_gemma":[0.0006731491,0.01319199,0.9721172,0.0002713677,0.0004415992,0.009081743,0.001734101,0.0005997278,0.0006222824,0.0001389012,0.0010873,0.00004068077],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982028,0.001211473,0.0000895981,0.00004783654,0.0000130065,0.00001905772,0.00008850131,0.00000216892,0.0003256283],"genre_scores_gemma":[0.9992431,0.0004384798,0.00005347695,0.00003724182,0.00003356884,0.00001379807,0.0001289501,0.000001790207,0.00004950334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001271471,"threshold_uncertainty_score":0.006397367,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0288229994142758,"score_gpt":0.2754209738416337,"score_spread":0.2465979744273579,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}